|Videos|May 25, 2023
Interview with Rentschler Biopharma's Federico Pollano
Author(s)Rentschler Biopharma
KEY LEARNING OBJECTIVES
- Viewers will gain a clear understanding of Rentschler Biopharma’s US offering currently and in the near future
- Viewers will understand what sets Rentschler Biopharma apart from other CDMOs in the field
- Viewers will gain a good feel for what it is like to be a client of Rentschler Biopharma
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Pharmaceutical Technology Is Now PharmTech: A Sharper Name for a Smarter Industry
2
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
3
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
4
GSK’s RSV Vaccine Approved in Europe
5